Diacerein
Back to searchMolecule Structure
Scientific Name
Diacerein
Description of the Drug
Diacerein is an slow-onset anthraquinone IL-1 inhibitor used in the treatment of degenerative joint diseases like osteoarthritis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB11994
http://www.drugbank.ca/drugs/DB11994
Brand Name(s)
Fisiodar
Company Owner(s)
Not Available
Mechanism(s) Of Action
Not Available
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL25784 |
| Human Metabolome Database | HMDB0251118 |
| DrugBank | DB11994 |
| PubChem: Thomson Pharma | 14901773 |
| PubChem | 26248 |
| Mcule | MCULE-3526700960 |
| LINCS | LSM-5766 |
| Nikkaji | J14.479G |
| BindingDB | 32018 |
| EPA CompTox Dashboard | DTXSID4045636 |
| DrugCentral | 849 |
| ChemicalBook | CB0755179 |
| Guide to Pharmacology | 10800 |
| rxnorm | DIACETYLRHEIN |
| PubChem: Drugs of the Future | 12012675 |
| ChEBI | 94708 |
| ZINC | ZINC000003812842 |
